|
BMPR2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.456400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.760000E-01 |
| Normal-vs-Stage2 |
6.910800E-01 |
| Normal-vs-Stage3 |
8.446600E-01 |
| Normal-vs-Stage4 |
2.610400E-01 |
| Stage1-vs-Stage2 |
9.119400E-01 |
| Stage1-vs-Stage3 |
3.084000E-01 |
| Stage1-vs-Stage4 |
7.830000E-02 |
| Stage2-vs-Stage3 |
5.522400E-01 |
| Stage2-vs-Stage4 |
1.824210E-01 |
| Stage3-vs-Stage4 |
3.383000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.258000E-01 |
| Normal-vs-AfricanAmerican |
2.427400E-01 |
| Normal-vs-Asian |
8.844600E-01 |
| Caucasian-vs-AfricanAmerican |
3.007800E-01 |
| Caucasian-vs-Asian |
9.901400E-01 |
| AfricanAmerican-vs-Asian |
3.562800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.338600E-01 |
| Normal-vs-Female |
6.028000E-01 |
| Male-vs-Female |
3.699800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.231000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.993800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.816400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.589400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.703000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.784200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.317200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.349000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.320800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.890800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.243600E-01 |
| Classical-VS-Follicular |
9.273600E-02 |
| Classical-VS-Other |
2.065000E-01 |
| Classical-VS-Normal |
3.511200E-01 |
| Tall-VS-Follicular |
9.217800E-01 |
| Tall-VS-Other |
4.545400E-01 |
| Tall-VS-Normal |
8.131200E-01 |
| Follicular-VS-Other |
5.074800E-01 |
| Follicular-VS-Normal |
6.927800E-01 |
| Other-VS-Normal |
3.200000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.710400E-01 |
| Normal-vs-N1 |
2.425400E-01 |
| N0-vs-N1 |
2.475800E-01 |
|
|
